Free Trial

This company has been marked as potentially delisted and may not be actively trading.

OTCMKTS:CRTN

Cartesian (CRTN) Stock Price, News & Analysis

About Cartesian Stock (OTCMKTS:CRTN)

Advanced Chart

Key Stats

Today's Range
$0.40
$0.40
50-Day Range
N/A
52-Week Range
$0.05
$1.05
Volume
1,000 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CRTN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cartesian and its competitors with MarketBeat's FREE daily newsletter.

CRTN Stock News Headlines

RNAC Cartesian Therapeutics, Inc.
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
Why Is Cartesian Therapeutics (RNAC) Stock Down 5% Today?
Cartesian Therapeutics Inc RNAC
RENE - Cartesian Growth Corporation II
See More Headlines

CRTN Stock Analysis - Frequently Asked Questions

Cartesian, Inc. (OTCMKTS:CRTN) issued its quarterly earnings data on Monday, August, 15th. The business services provider reported ($0.06) earnings per share for the quarter. The business services provider earned $18.90 million during the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cartesian investors own include Cannabis Science (CBIS), UrtheCast (UR), Atossa Genetics (ATOS), Arrowhead Pharmaceuticals (ARWR), Arena Pharmaceuticals (ARNA), Approach Resources (AREX) and Aptose Biosciences (APTO).

Company Calendar

Last Earnings
8/15/2016
Today
7/19/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Consulting
Sub-Industry
N/A
Current Symbol
OTCMKTS:CRTN
Previous Symbol
NASDAQ:CRTN
CIK
1094814
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:CRTN) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners